TARA FY 2014 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$212M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$3M100.0% margin

Operating Income

-$8M-257.1% margin

Net Income

-$3M-113.4% margin

EPS (Diluted)

$-10.24

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$459,000

Balance Sheet

Total Assets

$85M

Total Liabilities

$2M

Stockholders' Equity

$82M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	-$27,000	+11018.5%
Operating Income	-$8M	-$7M	-6.4%
Net Income	-$3M	-$8M	+57.8%